BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Jazz Pharmaceuticals 

Corporate Headquarters
Fourth Floor, Connaught House

One Burlington Road
Dublin    4  Ireland
Phone: 353-1-634-7800 Fax: 353-1-634-7850


View Clinical Trials from BioPharm Insight

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a specialty biopharmaceutical company of over 875 employees focused on diverse portfolio of products and/or product candidates in the areas of sleep, hematology/oncology, pain and psychiatry.

Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has U.S. offices in Palo Alto, CA and Philadelphia, PA, and has offices in various other locations in Europe. The company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what they do to accomplish results by driving to achieve Jazz’s mission: to improve patients’ lives by identifying, developing and commercializing important specialty pharmaceutical products to address unmet patient needs, and operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence.

U.S. addresses:
3180 Porter Drive
Palo Alto, CA 94304

1818 Market Street
Philadelphia, PA 19103

 Key Statistics

Ownership: Public

Web Site: Jazz Pharmaceuticals
Symbol: JAZZ


 Company News
Jazz Pharmaceuticals (JAZZ) To Report 2015 First Quarter Financial Results On May 7, 2015 4/27/2015 9:59:35 AM
EUSA Pharma Successfully Launches As An Independent Profitable Pharmaceutical Business With Global Reach And A Portfolio Of Specialty Products Acquired From Jazz Pharmaceuticals (JAZZ) 3/23/2015 8:25:54 AM
Jazz Pharmaceuticals (JAZZ) Announces Full Year And Fourth Quarter 2014 Financial Results 2/25/2015 9:20:40 AM
Jazz Pharmaceuticals (JAZZ) Announces Participation In Two Investor Conferences In March 2/24/2015 7:58:29 AM
Jazz Pharmaceuticals (JAZZ) To Present Data On Defibrotide, An Investigational Treatment, In Patients With Hepatic Veno-Occlusive Disease (VOD) At BMT Tandem Meetings 2/12/2015 7:36:13 AM
Jazz Pharmaceuticals (JAZZ) To Report 2014 Fourth Quarter And Full Year Financial Results On February 24, 2015 2/11/2015 10:35:17 AM
Jazz Pharmaceuticals (JAZZ) Signs Lease for Big Space in Palo Alto 1/13/2015 3:32:36 PM
Jazz Pharmaceuticals (JAZZ) To Present At J.P. Morgan Healthcare Conference On January 12 1/6/2015 8:37:11 AM
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014 7:40:56 AM
Jazz Pharmaceuticals (JAZZ) Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease 12/12/2014 7:36:03 AM